Strados Labs logo

Asthma

Remotely monitor cough and wheeze in asthma patients with the RESP® Biosensor

Asthma poses a huge burden on society and healthcare systems affecting 300 million globally, with prevalence and disease burden continuing to rise.1 Highly common in children, the disease is among the top causes of pediatric ED visits and missed school days.2
As clinicians and drug developers look for new ways to strengthen disease surveillance and insight into treatment response, continuous wheeze and cough monitoring offers a promising approach. Wheezing, a hallmark symptom of asthma and an indication of airway obstruction is typically observed only subjectively by patients or clinicians via auscultation. Cough is also a prevalent, burdensome symptom in asthma — especially in cough variant asthma — and a common early sign of an attack.3
The RESP® Biosensor, a wearable asthma monitoring device, offers direct, reliable metrics on cough and wheeze, providing enhanced insight into disease burden alongside patient self-reporting and pulmonary function tests.

The RESP® Biosensor: An FDA-Cleared Wearable for Monitoring Wheeze and Cough in Asthma

  • Clinically validated accuracy, with equivalent performance to Littman 3200 stethoscope.
  • Continuous monitoring of cough and lung sounds such as wheeze to offer quantitative data on respiratory symptoms in daily life.
  • Patient-friendly, reduces the burden on patients while improving clinician efficiency.
Certifications: FDA 510(k) clearance, CE Mark, HIPAA Compliant
Strados Cough Monitoring Solution

Just Completed: Asthma Validation Study in Children with Wheeze

Initial results from the study which took place at Ann & Lurie Children’s Hospital in Chicago showed positive feedback from patients and families as well as strong accuracy in detecting wheeze compared to physician auscultation.

Learn More

Download the Strados Publication

Continuous Monitoring Versus Intermittent Auscultation of Wheezes

Healthcare Settings

Manage lung health from hospital to home with real-time monitoring of symptoms

Learn More

Life Sciences

Gain greater, objective insight into subject treatment response in clinical trials

Learn More

Expert Overread and Data Reporting

  • Smart Reporting in Action: Our respiratory experts, trained annotators, and machine learning algorithms work in tandem to analyze cloud-uploaded patient cough and lung sound results with exceptional clinical accuracy.
  • Efficiency and Accuracy: Streamlined data annotation with our proprietary algorithms accelerates insights and optimizes research budgets, maintaining the integrity of every dataset.
**Machine learning algorithms not FDA-cleared
Lung sound recordings are depicted as spectrograms to facilitate overread
Cough graph

Cough

Wheeze graph

Wheeze

Crackles graph

Crackles

Clinical Validation

Explore our peer reviewed performance testing, studies and publications.

Continuous Monitoring vs Intermittent Auscultation of Wheezes in Patients Presenting with Acute Respiratory Distress

Remote auscultation at home after asthma exacerbation: a case from discharge to readmission

Results of Clinical Performance Testing in Chronic Lung Diseases

Is the RESP® Biosensor reimbursable?

The RESP® Biosensor is reimbursable under RPM and RTM codes.

Is the RESP® Biosensor designed for continuous long-term monitoring?

Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day. 

Which care settings is the RESP® Biosensor intended for?

The RESP® Biosensor is designed to be used across multiple care settings, including clinical trials,  in-patient, transitional care, post-acute discharge, outpatient, and hospital at home. 

Let’s Talk.

We’d love to know how we can help you and your patients.
Contact Us

References

  1. Wang, Z., Li, Y., Gao, Y., Fu, Y., Lin, J., Lei, X., Zheng, J., & Jiang, M. (2023). Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respiratory research, 24(1), 169. https://doi.org/10.1186/s12931-023-02475-6
  2. Asthma and Allergy Foundation of America. Asthma Facts and Figures [Internet] Available at https://aafa.org/asthma/asthma-facts/
  3. NHS. Asthma Attacks [Internet]. https://www.nhs.uk/conditions/asthma/asthma-attack/